Class / Patent application number | Description | Number of patent applications / Date published |
424044000 | Gas produced in situ by chemical reaction | 40 |
20080199409 | Effervescent Acidified Rehydration Preparations - An effervescent acidified rehydration preparation for administration in the drinking water of mammals and poultry includes an amount of a dry generally water soluble acidified electrolyte composition for treatment of dehydration in animals including mammals and poultry by oral administration in the drinking water of animals of interest and an amount of a pH balanced effervescent composition including an amount of one or more compatible water soluble organic acid species and an amount of one or more water soluble effervescent agents wherein effervescence occurs immediately upon the rehydration preparation being added to water. | 08-21-2008 |
20080206154 | Single-Stranded Antimicrobial Oligonucleotides and Uses Thereof - The current invention is directed to oligonucleotide sequences isolated from a sequence designated rbl-1 [SEQ ID NO. 19] that either kill or inhibit growth, or prevent the production of endogenously expressed toxin, of microorganisms. These ssDNA sequences, identified through use of a screening method, appear to act as modulators of essential growth functions which may act at the level of triplex formation, antisense inhibition, or as aptamers that alter gene function. The sequences, referred to as minimum functional regions, or MFRs, are useful inter alia as therapeutic agents for treatment of sepsis and other pathologies caused by microorganisms such as sepsis and/or in which microorganisms are contributory agents. | 08-28-2008 |
20080206155 | STABLE NON-ALCOHOLIC FOAMABLE PHARMACEUTICAL EMULSION COMPOSITIONS WITH AN UNCTUOUS EMOLLIENT AND THEIR USES - A stable non-alcoholic foamable pharmaceutical emulsion composition includes an unctuous emollient, at a concentration of about 0.5% to about 49% by weight; at least one multi-active agent; at a concentration of about 0.5% to about 15% by weight; water; an effective amount of an active pharmaceutical agent having a degree of solubility in the emulsion composition; and at least one liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition; wherein the unctuous emollient comprises a petrolatum alone or in combination with other unctuous agents; wherein the multi active agent is selected from the group consisting of (a) two or more complex emulgators wherein there is a difference of about 4 or more units between the HLB values of two of the emulgators or there is a significant difference in the chemical nature or structure of two of the emulgators; (b) a surfactant and a foam adjuvant or co surfactant, wherein the surfactant has a HLB close to the required HLB of the oil phase; (c) a surfactant and a liquid wax, wherein the surfactant has a HLB close to the required HLB of the oil phase; (d) a surfactant and a polymeric agent other than starch or a modified starch ester, wherein the surfactant has a HLB close to the required HLB of the oil phase; (e) a polymeric agent and a foam adjuvant or co surfactant, which can cooperate to stabilize the emulsion; (f) a single surfactant without a long polymeric side chain that is composed of a mixture of esters having a HLB close to the required HLB of the oil phase; combinations of any of the above, and wherein the composition is substantially flowable is stored in an pressurized container and upon release expands to form a breakable foam. | 08-28-2008 |
20080241076 | Method and composition for increasing Erythropoietin - This invention pertains to method and compositions for the purpose of increasing serum level of Erythropoietin (EPO) and the subsequent increase of red blood cells leading to an increase in athletic endurance. | 10-02-2008 |
20090238769 | Compositions Comprising Nonionic And Zwittterionic Surfactants - An foaming agent comprising a non-ionic surfactant, zwitterionic surfactant, and free of anionic surfactants which is suitable for use in personal care products, e.g., dentifrice compositions, e.g., for use in the treatment and/or alleviation of xerostomia. | 09-24-2009 |
20100021393 | Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate - A pharmaceutical composition comprising at least one effervescent agent and a fibrate and a process for making such composition. The fibrate is fenofibrate and the effervescent agent are in a dosage form. The dosage form increases dissolution and absorption of fenofibrate in biological conditions where the form contacts acidic gastric fluid after oral administration. | 01-28-2010 |
20100074849 | ORGANIC ACID FREE EFFERVESCENT FORMULATION - This invention provides a tablet that effervesces and significantly warms the water that it is dissolved in. The effervescence acts to break up the tablet allowing an exothermic material to rapidly dissolve releasing its heat of solution. The invention is unique in that no organic acid is required to form a conventional effervescent couple. | 03-25-2010 |
20100092400 | Salicylic Acid Composition - Provided, among other things, is a delivery module for water-based salicylic acid composition comprising: an aerosol delivery system; within the aerosol delivery system, the salicylic acid composition comprising 0.5% or more salicylic acid by weight, lipophilic component(s), and a frothing agent, the salicylic acid composition having a viscosity low enough to support aerosol delivery, and the salicylic acid composition effective to form a foam upon propellant-driven aerosol delivery; and within the aerosol delivery system, a propellant, wherein the salicylic acid composition is non-irritating and has a non-watery feel. | 04-15-2010 |
20100111877 | Foam disinfectant - The invention relates to an aqueous foam disinfectant comprised of a special surfactant system, which consists of non-ionic and amphoteric surfactants, and of a synergistic disinfectant constituent, which consists of an antimicrobial agent having amino groups and of at least one additional antimicrobial agent. | 05-06-2010 |
20100316577 | KIT COMPRISING AN ALGINATE AND A COMPLEXING AGENT IN THE FORM OF A WATER-INSOLUBLE SALT - The present patent application relates to a keratin material coating kit comprising: a first composition comprising an aqueous phase, at least one alginic acid-based compound and at least one agent for complexing the said compound, the said agent being in the form of a water-insoluble salt and being capable of releasing a gas on contact with an acid having a pKa ranging from 1 to 6, and a second composition comprising an acid having a pKa ranging from 1 to 6. | 12-16-2010 |
20110044914 | CLEANING COMPOSITIONS AND METHODS - The present invention is directed to effervescent cleaning compositions comprising a basic amino acid. | 02-24-2011 |
20110070169 | Effervescent Oral Fentanyl Dosage Form and Methods of Administering Fentanyl - Fentanyl-containing dosage forms and methods using same are described. These dosage forms include substantially less fentanyl by weight than known oral formulation and have advantages in terms of reduced cost and reduced side effects. These dosage forms are intended for oral administration of fentanyl across the oral mucosa. | 03-24-2011 |
20110206621 | ORAL TRANSMUCOSAL NICOTINE DOSAGE FORM - The invention described herein relates to an oral transmucosal solid dosage form useful in treating nicotine addiction or as a nicotine substitute or replacement. By virtue of the formulation in combination with nicotine, the invention transmucosally delivers an effective amount of nicotine to the recipient while permitting the accomplishing of such, and manufacture of such, using a relatively small, convenient and orally comfortable dosage form (e.g., tablet) size. | 08-25-2011 |
20110206622 | Effervescent Compositions Comprising Phosphonates and Methods Related Thereto - The invention provides effervescent composition comprising a bisphosphonate, an acidic compound, an alkaline effervescing component, and optionally an anti-ulcer agent and methods of treating osteoporosis in a mammal using the effervescent compositions. | 08-25-2011 |
20110223115 | SUBLINGUAL BUCCAL EFFERVESCENT - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed. | 09-15-2011 |
20110268666 | NOVEL GASTRORETENTIVE DELIVERY SYSTEM - A novel gastroretentive delivery system comprising a tablet comprising a pharmaceutical ingredient or diagnostic, which tablet comprises a gas releasing ingredient or a tandem of two gas releasing ingredients, an ingredient capable of unrestricted swelling in gastric fluid, an ingredient capable of limiting the unrestricted swelling and a hardening ingredient. The said system is based on the use of three different gastroretentive mechanisms: flotation, swelling and mechanical strength, the three mechanisms acting in a complimentary way. Processes for manufacturing same and methods of treatment are also disclosed. | 11-03-2011 |
20120058055 | GASTRORENTENTIVE ORAL HIGH DOSE ZINC PREPARATIONS - A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a sustained-release zinc composition. | 03-08-2012 |
20120093738 | TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS - The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration comprise one or more influenza antivirals, at least one taste-masking agent and at least one pharmaceutically acceptable excipient. Further, the taste-masked influenza antiviral formulations of the present invention are provided in the form of dispersible tablets, effervescent tablets, orally disintegrating tablets, chewable tablets, bite-dispersion tablets or the like, wherein the bitter taste of influenza antivirals is masked thereby providing palatable formulations. | 04-19-2012 |
20120282188 | COSMETIC PRODUCT - A cosmetic product includes at least: a first anhydrous cosmetic composition including at least colouring particles that are solid at room temperature and atmospheric pressure, the particles being formed from: at least one hydrophilic dyestuff in a content of greater than or equal to 60% by weight relative to their total weight, at least one effervescent system in a content of less than or equal to 20% by weight relative to their total weight, at least one hydrophilic binder, and at least one dispersant that is different from the hydrophilic binder; and a second composition comprising at least one aqueous phase. | 11-08-2012 |
20130004434 | Gastroretentive, Extended Release Composition Of Therapeutic Agent - A gastroretentive, extended release composition which floats and swells at acidic pH prevalent in the stomach. The composition includes a pH dependent graft copolymer, a gellable polymer, a therapeutic agent, a gas generating system and pharmaceutically acceptable ingredients. The disclosed composition is useful to deliver the therapeutic agent within the stomach for an extended period of time. | 01-03-2013 |
20130017156 | CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF - The invention features pharmaceutically acceptable salts of cefdinir, including primary, secondary, and tertiary amine salts of cefdinir, and preparation methods, and pharmaceutical compositions including cefdinir. The invention also features water dispersible pharmaceutical dosage forms including cefdinir as active agent and methods for preparing the dosages. The invention also features tablet forms of cefixime characterized in that the tablets are in effervescent form. The invention also features the process for preparing effervescent tablet forms with cefdinir as active agents and pharmaceutical formulations obtained by the process. | 01-17-2013 |
20130028844 | PREPARATIONS FOR EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND USES THEREOF - The present invention relates to a process for preparing effervescent dosage forms comprising at least one antibiotic of cephalosporin group. The present invention also relates to effervescent formulations and preparations comprising antibiotics of second generation cephalosporin. | 01-31-2013 |
20130149253 | ORAL DOSAGE FORM OF PREGABALIN - The invention relates to oral dosage forms of pregabalin, preferably for the modified release, and to processes for producing it. | 06-13-2013 |
20130156707 | PLANT EXTRACTS MADE OF SIDERITIS AND USE THEREOF TO BOOST COGNITIVE PERFORMANCE - The invention relates to aboveground plant parts of | 06-20-2013 |
20130164227 | PRODUCTION METHOD AND EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND CLAVULANIC ACID - The present invention relates to the process for the preparation of the pharmaceutical formulations comprising a cephalosporin antibiotic and clavulanic acid or any pharmaceutically acceptable derivative thereof. The present invention also relates to processes for preparation of said formulations and their use in bacterial infections. | 06-27-2013 |
20130287706 | STABLE EFFERVESCENT BISPHOSPHONATE FORMULATIONS WITH RAPID SOLUBILIZATION CHARACTERISTICS - A stable effervescent tablet, granule or powder composition free from excipients that may react with an effervescing organic acid component, comprising, an effective amount of a bisphosphonate bone resorption inhibitor, an effervescing organic acid component, an effervescing base component; wherein said composition is free of polyol binders and tableting lubricants; has a loss on drying of 0.25% (m/m) or less; has a complete disintegration time of no more than 180 seconds when placed in 3 to 8 fluid ounces of water at between 5-20° C.; and said bisphosphonate is incorporated as a micronized particle or by spray drying and is completely solubdised in water within 2 minutes without stirring. | 10-31-2013 |
20130302259 | EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE - Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described. | 11-14-2013 |
20130344005 | BOLUS FOR TREATING HYPOCALCAEMIA IN RUMINANTS - The subject of the invention is a veterinary product or a nutrition product intended in particular for the prevention and treatment of hypocalcaemia in ruminant animals. The product is in the form of a bolus comprising calcium carbonate and calcium formate. Advantageously, two of these boluses are concomitantly administered, one being a rapid-release effervescent bolus and the other being a slow-release bolus. | 12-26-2013 |
20140079646 | PHARMACEUTICAL FORMULATION FOR TREATING THE UPPER DIGESTIVE TRACT - The invention relates to an effervescent tablet for preparing a mouth rinsing solution, wherein the effervescent tablet exhibits a high release rate of budesonide. A high availability of the active ingredient during use as a mouth rinsing solution on the inflamed mucosa of the upper digestive tract is thereby achieved. The advantage of the formulation according to the invention lies in the bioavailability comparable to oral forms of administration, which allows the formulation to be used safely over an extended period of time. | 03-20-2014 |
20140079647 | CEFDINIR AND CEFIXIME FORMULATIONS AND USES THEREOF - The invention features pharmaceutically acceptable salts of cefdinir, including primary, secondary, and tertiary amine salts of cefdinir, and preparation methods, and pharmaceutical compositions including cefdinir. The invention also features water dispersible pharmaceutical dosage forms including cefdinir as active agent and methods for preparing the dosages. The invention also features tablet forms of cefixime characterized in that the tablets are in effervescent form. The invention also features the process for preparing effervescent tablet forms with cefdinir as active agents and pharmaceutical formulations obtained by the process. | 03-20-2014 |
20140120039 | FOAMING SKINCARE FORMULATIONS - In one aspect, the present invention is directed to formulations comprising at least one pressure generating vehicle along with at least one skincare active agent in a container such that the pressure generating vehicle would eject the formulation as foam, whipped cream or a similar form upon application of external pressure on the container. | 05-01-2014 |
20140234228 | EFFERVESCENT COMPOSITIONS CONTAINING N-ACETYLCYSTEINE - Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described. | 08-21-2014 |
20150086488 | Method For Applying A Foaming Cosmetic Composition - The invention relates to a method for applying a cosmetic composition to hair. The method comprises the steps of removing a cosmetic composition from a sealed container, the composition comprising: a post-foaming emulsion comprising a weak acid, a weak base, a fatty acid, and a volatile buffering agent; a film forming agent; and an aqueous carrier; applying said composition to one or more eyelashes; and during or after said application to said one or more eyelashes, said cosmetic composition forms a foam, said foam resulting from the release of a gas, said gas being a reaction product of said post-foaming emulsion, and said reaction commencing after the evaporation of said volatile buffering agent, upon exposure of said cosmetic composition to atmospheric conditions. | 03-26-2015 |
20150147279 | PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING CEPHALOSPORIN AND USES THEREOF - The present invention relates to a process for preparing effervescent dosage forms comprising at least one antibiotic of cephalosporin group. The present invention also relates to effervescent formulations and preparations comprising antibiotics of second generation cephalosporin. | 05-28-2015 |
20150313213 | EXTENDED RELEASE TABLET AND METHOD FOR MAKING AND USING SAME - Provided are cap layer compositions and base layer compositions, providing quick and extended release of an active ingredient, respectively, when placed in water. Further provided are dual release compositions including a base composition and a cap composition. The base composition may include a plaster and an active agent, and it may further include at least one of a water-soluble binder, a non-water-soluble binder, and a lubricant. The cap composition may include a plaster and an active agent, and it may further include at least one of a disintegrating agent, a non-water-soluble binder, and a lubricant. The compositions may be heated and mixed and formed into a tablet. Further provided are methods of making the compositions. Further provided are methods of controlling or eliminating pests and methods of increasing the potability of water. The compositions are effective for controlling or eliminating pests such as mosquitoes when applied at an application site. | 11-05-2015 |
20150328155 | GEL COMPOSITION CAPABLE OF USE AS A DRUG DELIVERY DEVICE AND METHOD OF USE THEREOF - The present invention provides a gel composition intended for use as a drug delivery device, particularly for use in the sinus cavity. The gel composition can include a gelling agent that includes at least one polysaccharide, a propellant in the form of a sterile gas, and optionally, at least one active ingredient. The polysaccharide can be selected from the group consisting of hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, carrageenans, and combinations thereof. | 11-19-2015 |
20150342965 | FOAMABLE OTIC PHARMACEUTICAL COMPOSITIONS - The present invention relates to foamable otic pharmaceutical compositions comprising oil-in-water emulsions which comprise an antibiotic agent and a propellant gas. The pharmaceutical compositions are administered to the ear as foam for treating ear disorders. | 12-03-2015 |
20150366858 | Methods for Treating Infections - The present invention relates to methods for treating, preventing, or reducing the risk of microbial infections while minimizing adverse gastrointestinal effects using a two-stage dosing regimen comprising about 1 to about 7 days of intravenous administration followed by about 1 to about 14 days of oral administration of an antimicrobial agent. | 12-24-2015 |
20160067155 | FOAMABLE COSMETIC PRODUCT - Provided is a cosmetic product which can generate a carbon dioxide gas to cause foaming by a simple method and having excellent usability. Provided is a cosmetic product comprising a first composition and a second composition different from the first composition as constituent elements of the cosmetic product and which foams by mixing the first composition and the second composition, wherein the first composition is a liquid or creamy composition containing a bicarbonate and/or a carbonate, and the second composition is a liquid or creamy composition containing an α-hydroxy acid and/or a saturated dibasic acid in which the content of water is 1.0-fold or less in terms of weight ratio with respect to the α-hydroxy acid and/or the saturated dibasic acid. | 03-10-2016 |
20160106646 | COSMETIC KIT COMPRISING EFFERVESCENT TABLET AND SKIN TONER - One aspect of the present invention relates to an effervescent tablet comprising a water-soluble lubricating agent, and a carbonated water cosmetic composition enabled to be used together therewith. One aspect of the present invention relates to an effervescent tablet comprising a crystalline #-hydroxy acid and a water-soluble lubricating agent, and a cosmetic composition using a skin toner for preventing the tablet from floating and allowing the tablet to rapidly form carbon dioxide gas in the cosmetic composition so as to maximize the visual effect and also the effect of carbon dioxide, thereby showing skin whitening, brightening and moisturizing effects and improving the pores. | 04-21-2016 |